Kessler Foundation seeks participants for research studies
/
Date18 Oct 2016
EAST HANOVER, N.J., Oct. 18, 2016 (GLOBE NEWSWIRE) — Kessler Foundation is recruiting study participants for multiple research programs aimed at improving cognition, mobility, and... Read More →
RedHill Biopharma Announces Allowance of a Patent in Japan Supporting RHB-104 for Multiple Sclerosis
/
Date18 Oct 2016
RedHill has received from the Japan Patent Office a Notice of Allowance for a new patent covering RHB-104 for multiple sclerosis (MS), expected to be... Read More →
EMSCHARTS ANNOUNCES RELEASE OF TABLET APPLICATION
/
Date18 Oct 2016
PITTSBURGH, Oct. 18, 2016 (GLOBE NEWSWIRE) — emsCharts, the leader in Electronic Patient Care Record (ePCR) and fire reporting for public safety professionals, is proud... Read More →
Dimension Therapeutics Announces Presentations Highlighting Advances in AAV Manufacturing at the European Society of Gene and Cell Therapy (ESGCT) Congress
/
Date18 Oct 2016
CAMBRIDGE, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) — Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the liver,... Read More →
INC Research Marks 20-Year Milestone in Managing Antiretroviral Pregnancy Registry
/
Date18 Oct 2016
RALEIGH, N.C., Oct. 18, 2016 (GLOBE NEWSWIRE) — INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, is commemorating... Read More →
Adaptimmune Announces Initiation of Triple Tumor Study to Evaluate its SPEAR® T-Cell Therapy Targeting MAGE-A10
/
Date18 Oct 2016
PHILADELPHIA and OXFORD, United Kingdom, Oct. 18, 2016 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced... Read More →
Bob Woodruff Foundation Establishes Interim Funding for Injured Veteran IVF Services
/
Date18 Oct 2016
NEW YORK, Oct. 18, 2016 (GLOBE NEWSWIRE) — The Bob Woodruff Foundation celebrates the culmination of months of work by Congress and advocacy by multiple... Read More →
Atara Bio Granted Access to Priority Medicines (PRIME) Regulatory Support for Allogeneic Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes (CTL) for Treatment of EBV-Associated Post Transplant Lymphoproliferative Disorder (EBV-PTLD)
/
Date18 Oct 2016
SOUTH SAN FRANCISCO, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) — Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and... Read More →
Neurovascular Devices Market size worth over $2.3bn by 2024: Global Market Insights Inc.
/
Date18 Oct 2016
Ocean View, Delaware, Oct. 18, 2016 (GLOBE NEWSWIRE) — Neurovascular Devices Market size will exceed USD 2.3 billion by 2024; according to a new research... Read More →
Global Medical Aesthetic Devices Market worth USD 11.20 Billion by 2021: By Product, Application, Industry Size, Share and Growth
/
Date18 Oct 2016
Sarasota, FL, Oct. 18, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Medical Aesthetic Devices Market (Aesthetic Laser and Energy Devices,... Read More →